专题:Coagulation, Bradykinin, Polyphosphates, and Angioedema

This cluster of papers focuses on the molecular mechanisms, pathophysiological consequences, and clinical management of Hereditary Angioedema. It covers topics such as the role of kinin receptors, coagulation factors XII and XI, polyphosphate, C1 inhibitor deficiency, and the use of bradykinin-receptor antagonists in the treatment of angioedema. Additionally, it explores the involvement of tissue kallikreins and the contact activation system in the disease pathology.
最新文献
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis

article Full Text OpenAlex

Repeated convergent evolution of bradykinin mimics as defensive toxins

article Full Text OpenAlex

A severe case of rhabdomyolysis, acute kidney injury, cardiogenic shock, and chronic complications caused by an excessively large dose of Tripterygium glycoside

article Full Text OpenAlex

Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial

article Full Text OpenAlex

The Duke MG Patient Registry III . Comparative Effectiveness of Azathioprine and Mycophenolate Mofetil in Generalized Myasthenia Gravis, a Retrospective Single Center Review

article Full Text OpenAlex

APOL1 plasma membrane pools resist rapid protein degradation

article Full Text OpenAlex

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study

article Full Text OpenAlex

The Complement System in ANCA‐Associated Vasculitis: Mechanistic Insights, Therapeutic Horizons, and Unmet Clinical Needs

article Full Text OpenAlex

High-Purity Isolation of Polyphosphate-Rich Stabilisomes Defines Their Conserved Chemical Architecture in Thermophilic Cyanobacteria

article Full Text OpenAlex

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

article Full Text OpenAlex

近5年高被引文献
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

article Full Text OpenAlex 449 FWCI62.8847

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

article Full Text OpenAlex 346 FWCI27.9587

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

article Full Text OpenAlex 296 FWCI43.8959

A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology

review Full Text OpenAlex 255 FWCI72.4498

UpdatedS2K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

article Full Text OpenAlex 227 FWCI30.9538

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

article Full Text OpenAlex 205 FWCI41.371

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

article Full Text OpenAlex 194 FWCI31.926

Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

letter Full Text OpenAlex 188 FWCI25.2168

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

article Full Text OpenAlex 181 FWCI36.8983

Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial

article Full Text OpenAlex 181 FWCI26.7757